clonidine has been researched along with Dermatitis Medicamentosa in 22 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy and safety of two different galenic formulations of transdermal clonidine systems were compared in 905 patients with mild to moderate essential hypertension during a 12 weeks observation period." | 9.07 | Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension. ( Göbel, BO; Kolloch, RE; Mehlburger, L; Schumacher, H, 1993) |
| "The clonidine patch offers for the first time the unique possibility of a once-a-week transdermal therapy of hypertension due to direct absorption of clonidine through the skin." | 9.07 | One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators. ( , 1993) |
| "The long-term safety and efficacy of transdermal clonidine (C-TTS) was evaluated in 102 patients with mild to moderate hypertension over a mean treatment period of 4." | 9.07 | Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension. ( Breidthardt, J; Mehlburger, L; Schumacher, H, 1993) |
| "We compared the effects of transdermal clonidine and oral atenolol on acute exercise performance and on conditioning response to an 8-week program of regular aerobic exercise in young, otherwise healthy subjects with mild hypertension." | 9.06 | Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension. ( Davidman, M; Davies, SF; Graif, JL; Husebye, DG; Iber, C; Maddy, MM; McArthur, CD; O'Connell, MB; Path, MJ, 1989) |
| "The efficacy and safety of two different galenic formulations of transdermal clonidine systems were compared in 905 patients with mild to moderate essential hypertension during a 12 weeks observation period." | 5.07 | Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension. ( Göbel, BO; Kolloch, RE; Mehlburger, L; Schumacher, H, 1993) |
| "The clonidine patch offers for the first time the unique possibility of a once-a-week transdermal therapy of hypertension due to direct absorption of clonidine through the skin." | 5.07 | One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators. ( , 1993) |
| "The long-term safety and efficacy of transdermal clonidine (C-TTS) was evaluated in 102 patients with mild to moderate hypertension over a mean treatment period of 4." | 5.07 | Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension. ( Breidthardt, J; Mehlburger, L; Schumacher, H, 1993) |
| "We compared the effects of transdermal clonidine and oral atenolol on acute exercise performance and on conditioning response to an 8-week program of regular aerobic exercise in young, otherwise healthy subjects with mild hypertension." | 5.06 | Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension. ( Davidman, M; Davies, SF; Graif, JL; Husebye, DG; Iber, C; Maddy, MM; McArthur, CD; O'Connell, MB; Path, MJ, 1989) |
| "Transdermal clonidine was approved by the US Food and Drug Administration in 1984 for the treatment of mild-to-moderate hypertension alone or in combination with a diuretic." | 3.73 | Transdermal clonidine: therapeutic considerations. ( Grubbs, R; Sica, DA, 2005) |
| " Methods also have been developed to determine the skin irritation potential of a drug substance during the preclinical stages of transdermal dosage form development." | 2.66 | Testing of controlled-release transdermal dosage forms. Product development and clinical trials. ( Amkraut, AA; Prevo, ME; Shaw, JE, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (50.00) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haas, N | 1 |
| Martens, F | 1 |
| Henz, BM | 1 |
| Sica, DA | 1 |
| Grubbs, R | 1 |
| Sills, M | 1 |
| Congdon, P | 1 |
| Forsythe, I | 1 |
| van Joost, T | 1 |
| Faber, WR | 1 |
| Manuel, HR | 1 |
| Kolloch, RE | 1 |
| Mehlburger, L | 2 |
| Schumacher, H | 2 |
| Göbel, BO | 1 |
| Breidthardt, J | 1 |
| Weber, MA | 2 |
| Kalish, R | 1 |
| Wood, JA | 1 |
| Wille, JJ | 1 |
| Kydonieus, A | 1 |
| Polster, AM | 1 |
| Warner, MR | 1 |
| Camisa, C | 1 |
| Britt, MT | 1 |
| Burnstine, MA | 1 |
| Ito, MK | 1 |
| O'Connor, DT | 1 |
| Davies, SF | 1 |
| Graif, JL | 1 |
| Husebye, DG | 1 |
| Maddy, MM | 1 |
| McArthur, CD | 1 |
| Path, MJ | 1 |
| O'Connell, MB | 1 |
| Iber, C | 1 |
| Davidman, M | 1 |
| Dick, JB | 1 |
| Northridge, DB | 1 |
| Lawson, AA | 1 |
| Hollifield, J | 1 |
| Shaw, JE | 1 |
| Prevo, ME | 1 |
| Amkraut, AA | 1 |
| Kellaway, GS | 1 |
| Lubbe, WF | 1 |
| Groth, H | 1 |
| Greminger, P | 1 |
| Vetter, H | 1 |
| Knüsel, J | 1 |
| Baumgart, P | 1 |
| Siegenthaler, W | 1 |
| Vetter, W | 1 |
| Grattan, CE | 1 |
| Kennedy, CT | 1 |
| Almeyda, J | 1 |
| Levantine, A | 1 |
1 review available for clonidine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Cutaneous reactions to cardiovascular drugs.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Debrisoquin; Digitalis Glycosides; | 1973 |
10 trials available for clonidine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Clonidine and childhood migraine: a pilot and double-blind study.
Topics: Child; Child, Preschool; Clinical Trials as Topic; Clonidine; Double-Blind Method; Drug Eruptions; F | 1982 |
Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension.
Topics: Administration, Cutaneous; Adult; Aged; Blood Pressure; Clonidine; Dose-Response Relationship, Drug; | 1993 |
One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
Topics: Administration, Cutaneous; Adult; Blood Pressure; Clonidine; Drug Eruptions; Female; Heart Rate; Hum | 1993 |
Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension.
Topics: Administration, Cutaneous; Adult; Aged; Blood Pressure; Clonidine; Dose-Response Relationship, Drug; | 1993 |
Skin pretreatment and the use of transdermal clonidine.
Topics: Administration, Cutaneous; Administration, Topical; Adult; Aged; Aluminum Hydroxide; Antacids; Cloni | 1991 |
Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Atenolol; Clonidine; Dermatitis, Contact; Do | 1989 |
Skin reactions to long-term transdermal clonidine.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Clonidine; Drug Eruptions; Humans; Hypertension | 1987 |
Clinical acceptability of transdermal clonidine: a large-scale evaluation by practitioners.
Topics: Administration, Cutaneous; Blood Pressure; Clinical Trials as Topic; Clonidine; Drug Eruptions; Fema | 1986 |
Transdermal antihypertensive therapy: clinical and metabolic considerations.
Topics: Administration, Cutaneous; Blood Pressure; Clinical Trials as Topic; Clonidine; Drug Eruptions; Huma | 1986 |
Testing of controlled-release transdermal dosage forms. Product development and clinical trials.
Topics: Administration, Cutaneous; Animals; Biological Availability; Clinical Trials as Topic; Clonidine; De | 1987 |
11 other studies available for clonidine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Miliaria crystallina in an intensive care setting.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Albuterol; Clonidine; Critical Care; Dru | 2004 |
Transdermal clonidine: therapeutic considerations.
Topics: Administration, Cutaneous; Clonidine; Drug Eruptions; Humans; Hypertension | 2005 |
Drug-induced anogenital cicatricial pemphigoid.
Topics: Anus Diseases; Clonidine; Drug Eruptions; Female; Humans; Middle Aged; Skin Diseases, Vesiculobullou | 1980 |
The sympathetic nervous system and hypertension: mechanisms and treatment.
Topics: Administration, Cutaneous; Clonidine; Drug Eruptions; Humans; Hypertension; Sympathetic Nervous Syst | 1993 |
Sensitization of mice to topically applied drugs: albuterol, chlorpheniramine, clonidine and nadolol.
Topics: Administration, Cutaneous; Albuterol; Animals; Anti-Asthmatic Agents; Antihypertensive Agents; Biolo | 1996 |
Allergic contact dermatitis from transdermal clonidine in a patient with mycosis fungoides.
Topics: Administration, Cutaneous; Aged; Antihypertensive Agents; Clonidine; Dermatitis, Allergic Contact; D | 1999 |
Iopidine allergy causing lower eyelid ectropion progressing to cicatricial entropion.
Topics: Adrenergic alpha-Agonists; Cicatrix; Clonidine; Drug Eruptions; Ectropion; Entropion; Humans; Male; | 1999 |
Cutaneous drug reaction case reports: from the world literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Capecitabine; Carbamates; Ceftriaxone; Clonidine; Deoxyc | 2002 |
Catapres-TTS: a two year posttrial followup.
Topics: Administration, Cutaneous; Clonidine; Drug Eruptions; Evaluation Studies as Topic; Follow-Up Studies | 1988 |
[Transdermal clonidine: a new therapeutic approach in essential hypertension?].
Topics: Administration, Topical; Adult; Aged; Blood Pressure; Clonidine; Drug Eruptions; Drug Therapy, Combi | 1985 |
Allergic contact dermatitis to transdermal clonidine.
Topics: Administration, Topical; Clonidine; Drug Eruptions; Humans; Male; Middle Aged | 1985 |